PT84219B - Processo para a preparacao de uma composicao antiviral contendo um nucleosido de purina antiviral e um nucleosido de transporte inibidor - Google Patents

Processo para a preparacao de uma composicao antiviral contendo um nucleosido de purina antiviral e um nucleosido de transporte inibidor

Info

Publication number: PT84219B
Authority: PT; Portugal
Prior art keywords: virulent; inhibitory; preparation; composition containing; nucleoside
Prior art date: 1986-01-30

Application number

PT84219A

Other languages

English (en)

Other versions

PT84219A (en

Original Assignee

Wellcome Found

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1986-01-30

Filing date

1987-01-29

Publication date

1989-07-31

1987-01-29 Application filed by Wellcome Found filed Critical Wellcome Found

1987-02-01 Publication of PT84219A publication Critical patent/PT84219A/pt

1989-07-31 Publication of PT84219B publication Critical patent/PT84219B/pt

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/76—Viruses; Subviral particles; Bacteriophages
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Chemical & Material Sciences (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Epidemiology (AREA)
Organic Chemistry (AREA)
Virology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Molecular Biology (AREA)
Mycology (AREA)
Oncology (AREA)
Engineering & Computer Science (AREA)
Microbiology (AREA)
Communicable Diseases (AREA)
Bioinformatics & Cheminformatics (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Saccharide Compounds (AREA)

PT84219A 1986-01-30 1987-01-29 Processo para a preparacao de uma composicao antiviral contendo um nucleosido de purina antiviral e um nucleosido de transporte inibidor PT84219B (pt)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
GB868602346A GB8602346D0 (en)	1986-01-30	1986-01-30	Antiviral combinations

Publications (2)

Publication Number	Publication Date
PT84219A PT84219A (en)	1987-02-01
PT84219B true PT84219B (pt)	1989-07-31

Family

ID=10592262

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PT84219A PT84219B (pt)	1986-01-30	1987-01-29	Processo para a preparacao de uma composicao antiviral contendo um nucleosido de purina antiviral e um nucleosido de transporte inibidor

Country Status (20)

Country	Link
US (1)	US4897394A (pt)
EP (1)	EP0235931B1 (pt)
JP (1)	JPS62195337A (pt)
KR (1)	KR870006900A (pt)
AT (1)	ATE54414T1 (pt)
AU (1)	AU590817B2 (pt)
CA (1)	CA1283361C (pt)
DD (1)	DD261095A5 (pt)
DE (1)	DE3763597D1 (pt)
DK (1)	DK46787A (pt)
ES (1)	ES2031883T3 (pt)
FI (1)	FI870377A7 (pt)
GB (1)	GB8602346D0 (pt)
GR (1)	GR3000638T3 (pt)
HU (1)	HU198394B (pt)
IL (1)	IL81422A0 (pt)
MC (1)	MC1791A1 (pt)
PL (1)	PL263871A1 (pt)
PT (1)	PT84219B (pt)
ZA (1)	ZA87667B (pt)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4800081A (en) *	1984-04-18	1989-01-24	Board Of Regents, The University Of Texas System	Methods and compositions for treating viral infections
US4782065A (en) *	1984-04-18	1988-11-01	Board Of Regents, The University Of Texas System	Methods and compositions for treating viral infections
US4849412A (en) *	1986-06-05	1989-07-18	Board Of Regents, The University Of Texas System	Methods and compositions for treating viral infections
US5580571A (en) *	1991-10-15	1996-12-03	Hostetler; Karl Y.	Nucleoside analogues
US5879700A (en) *	1991-10-15	1999-03-09	Hostetler; Karl Y.	Nucleoside analogue phosphates for topical use
WO1994018979A2 (en) *	1993-02-19	1994-09-01	Southern Research Institute	Methods of treatment of viral infections using carbocyclic deoxyguanosine analogs
AU6516494A (en) *	1993-04-15	1994-11-08	New York University	Adenosine receptor agonists for the promotion of wound healing
AU701574B2 (en) *	1993-05-12	1999-02-04	Karl Y. Hostetler	Acyclovir derivatives for topical use
US5654286A (en) *	1993-05-12	1997-08-05	Hostetler; Karl Y.	Nucleotides for topical treatment of psoriasis, and methods for using same
US6015573A (en) *	1993-05-12	2000-01-18	Hostetler; Karl Y.	Nucleoside phosphate therapy for viral infection
US6440980B1 (en)	1996-09-17	2002-08-27	Avanir Pharmaceuticals	Synergistic inhibition of viral replication by long-chain hydrocarbons and nucleoside analogs
US5677308A (en) *	1996-12-19	1997-10-14	Lerner; A. Martin	Method for alleviating spasmodic torticollis
US6399622B1 (en)	1997-02-18	2002-06-04	A. Martin Lerner	Method for diagnosing and alleviating the symptoms of chronic fatigue syndrome
US5872123A (en)	1997-02-18	1999-02-16	Lerner; A. Martin	Method for diagnosing and alleviating the symptoms of chronic fatigue syndrome
US6537997B1 (en)	1997-02-18	2003-03-25	A. Martin Lerner	Method for diagnosing and alleviating the symptoms of chronic fatigue syndrome
HRP20040421B1 (hr) *	2001-10-16	2013-05-31	Avanir Pharmaceuticals	INHIBICIJA VIRUSA n-DOKOZANOLOM
WO2013023362A1 (zh) *	2011-08-16	2013-02-21	深圳市卫武光明生物制品有限公司	静注巨细胞病毒人免疫球蛋白及其制备方法
US20140100238A1 (en)	2012-10-04	2014-04-10	Ohio State University	Method of diagnosing and treating epstein barr virus-based myalgic encephalomyelitis chronic fatigue syndrome patients
CN105079404A (zh) *	2015-09-07	2015-11-25	夏云强	一种治疗多重耐药菌所致感染性创面的中药外洗剂

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB2080106B (en) *	1980-07-18	1984-03-07	Weelcome Foundation Ltd	Acyclovin preparations
ATE33653T1 (de) *	1982-10-14	1988-05-15	Wellcome Found	Antivirale purinderivate.
GB8320308D0 (en) *	1983-07-28	1983-09-01	Wellcome Found	Antiviral combinations
FI87783C (fi) *	1985-05-15	1993-02-25	Wellcome Found	Foerfarande foer framstaellning av terapeutiskt anvaendbara 2',3'-dideoxinukleosider
DE3627024A1 (de) *	1985-09-24	1987-04-02	Hoechst Ag	In 6- und 9-stellung substituierte 2-aminopurine, ihre verwendung, diese purine enthaltende arzneimittel und verfahren zur herstellung der purine
MY101126A (en) *	1985-12-13	1991-07-31	Beecham Group Plc	Novel compounds

1986
- 1986-01-30 GB GB868602346A patent/GB8602346D0/en active Pending
1987
- 1987-01-28 KR KR870000667A patent/KR870006900A/ko not_active Withdrawn
- 1987-01-29 HU HU87280A patent/HU198394B/hu not_active IP Right Cessation
- 1987-01-29 PT PT84219A patent/PT84219B/pt unknown
- 1987-01-29 DD DD87299551A patent/DD261095A5/de unknown
- 1987-01-29 AT AT87300781T patent/ATE54414T1/de not_active IP Right Cessation
- 1987-01-29 DK DK046787A patent/DK46787A/da not_active Application Discontinuation
- 1987-01-29 ES ES198787300781T patent/ES2031883T3/es not_active Expired - Lifetime
- 1987-01-29 AU AU68135/87A patent/AU590817B2/en not_active Ceased
- 1987-01-29 MC MC871869A patent/MC1791A1/fr unknown
- 1987-01-29 DE DE8787300781T patent/DE3763597D1/de not_active Expired - Fee Related
- 1987-01-29 US US07/008,627 patent/US4897394A/en not_active Expired - Fee Related
- 1987-01-29 JP JP62019592A patent/JPS62195337A/ja active Pending
- 1987-01-29 FI FI870377A patent/FI870377A7/fi not_active Application Discontinuation
- 1987-01-29 EP EP87300781A patent/EP0235931B1/en not_active Expired - Lifetime
- 1987-01-29 ZA ZA87667A patent/ZA87667B/xx unknown
- 1987-01-29 IL IL81422A patent/IL81422A0/xx unknown
- 1987-01-29 CA CA000528515A patent/CA1283361C/en not_active Expired - Fee Related
- 1987-01-29 PL PL1987263871A patent/PL263871A1/xx unknown
1990
- 1990-07-12 GR GR90400403T patent/GR3000638T3/el unknown

Also Published As

Publication number	Publication date
FI870377A0 (fi)	1987-01-29
DE3763597D1 (de)	1990-08-16
ES2031883T3 (es)	1993-01-01
ATE54414T1 (de)	1990-07-15
JPS62195337A (ja)	1987-08-28
DD261095A5 (de)	1988-10-19
AU590817B2 (en)	1989-11-16
PT84219A (en)	1987-02-01
GR3000638T3 (en)	1991-09-27
FI870377L (fi)	1987-07-31
CA1283361C (en)	1991-04-23
DK46787A (da)	1987-07-31
US4897394A (en)	1990-01-30
IL81422A0 (en)	1987-08-31
ZA87667B (en)	1988-09-28
MC1791A1 (fr)	1987-10-22
HU198394B (en)	1989-10-30
FI870377A7 (fi)	1987-07-31
DK46787D0 (da)	1987-01-29
AU6813587A (en)	1987-08-06
EP0235931B1 (en)	1990-07-11
HUT42941A (en)	1987-09-28
KR870006900A (ko)	1987-08-13
EP0235931A1 (en)	1987-09-09
GB8602346D0 (en)	1986-03-05
PL263871A1 (en)	1988-05-12

Similar Documents

Publication	Publication Date	Title
PT84219B (pt)	1989-07-31	Processo para a preparacao de uma composicao antiviral contendo um nucleosido de purina antiviral e um nucleosido de transporte inibidor
EP0135713A3 (en)	1988-08-31	Antiviral combinations
EP0375329A3 (en)	1991-08-14	Antiviral pyrimidine and purine compounds, process for their preparation and pharmaceutical compositions containing them
PT80079B (pt)	1987-09-18	Processo para a preparacao de composicoes farmaceuticas anti-virus contendo 2-dietilamino-2',6'-acetoxilida (lidocaina)
PT1411954E (pt)	2011-03-16	Nucleosídeos modificados para o tratamento de infecções virais e proliferação celular anormal
MY121839A (en)	2006-02-28	Antiviral purine derivatives
FI20001231A7 (fi)	2000-05-23	2-Deoksi-2,3-didehydro-N-asetyylineuramiinihapon johdannaisia ja niiden analogeja ja niiden käyttö antiviraalisina aineina
IL104976A0 (en)	1993-07-08	Nucleoside analogues,their preparation and pharmaceutical compositions containing them
PT90972A (pt)	1989-12-29	Processo para a preparacao de inibidores de ribonucleotido-redutase, nomeadamente, de tiocarbono-hidrazonas e/ou hidrazinas substituidas e seus derivados e de composicoes farmaceuticas que os contem em associacao com outros compostos antivirais
KR900009083A (ko)	1990-07-02	2', 3'-디데옥시푸린 뉴클레오사이드/푸린 뉴클레오 사이드 포스포릴라제 억제제 배합 치료법 및 조성물
ATE411806T1 (de)	2008-11-15	DIE VERWENDUNG VON PYRIMIDINNUKLEOSIDEN UND/ODER PRODRUGS DAVON ZUR BEKÄMPFUNG VON NEBENWIRKUNGEN DER ßHAARTß (HIGHLY ACTIVE ANTI-RETROVIRAL THERAPY) UND ANDEREN ANTIVIRALEN THERAPIEN
ATE72122T1 (de)	1992-02-15	Antivirale mischungen.
De Clercq	1987	Antiviral nucleoside analogs.
Ohrui et al.	1993	Synthesis of conceptually new, potentially anti-viral, low-toxity, acid-and enzyme-stable furanoid and pyranoid nucleosides
Yamamoto et al.	1988	Inhibitory effect of sulphur-containing purine nucleoside analogues on replication of RNA viruses: selective antiviral activity against influenza viruses.
Kitano et al.	2000	Synthesis of 4′-ethynyl-purine nucleosides possessing anti-HIV activity
ES2357811T3 (es)	2011-04-29	Nucleósidos modificados para el tratamiento de infecciones virales y proliferación celular anormal.
KR890001560A (ko)	1989-03-27	항바이어러스 조성물
Shibata et al.	1981	Guanosine triphosphate (GTP) breakdown products in Antarctic krill Euphausia superba
ATE83926T1 (de)	1993-01-15	Antivirale anwendung von alpha-oligonucleotiden.
左丽 et al.	1998	Quantitative Study on Synergistic Effect of Radix Astragalus A6 and Acyclovir against Herpes Simplex Virus Type Ⅰ by Polymerase Chain Reaction
Sidwell et al.	2012	inhibited the replication of DNA viruses in vitro (Herrmann, 1961)
Bernaerts et al.	1984	On the mechanism of action of carbodine, a carbocyclic nucleoside analog with broad-spectrum antiviral activity.
MX9709782A (es)	1998-10-31	Derivados de aciclovir para aplicacion topica.